Scripps Revolutionizing Transplantation The Future of Genomics and Molecular Diagnostics in Organ Transplantation 2024

Advances in genomics and diagnostics are reshaping organ transplantation, promising improved patient outcomes. Current progress includes better immunosuppression, enhanced graft monitoring, and refined HLA typing for precise matches. However, new methods that spotlight viral surveillance and antibody monitoring, like donor-derived cell-free DNA analysis, are driving a transformative shift in transplant medicine. Looking to the future, precision medicine brings the promise of tailored treatments to reduce rejection and optimize grafts, integrating biomarkers with AI for a personalized approach. Innovations in multi-organ preservation, regenerative medicine, and xenotransplantation are also emerging. This conference will gather experts to discuss these advancements, offering insights into the current and future state of genomics in transplantation.

Educational Objectives
After attending this live activity, participants should be able to:
• Explore the transformative potential of genomics and diagnostics in multi-organ transplantation, focusing on the role of advanced techniques in tailoring immunosuppression management to individual patient needs for improved outcomes.
• Leverage genomic and diagnostic tools for precision medicine in transplantation to improve graft surveillance, detect complications early, and tailor treatments that minimize rejection, mitigate immunosuppression risks, and ensure optimal graft function and patient health.
• Evaluate the evolving landscape of genomics and diagnostics in transplantation to update practices and technologies and apply these insights to enhance patient care and outcomes in everyday clinical practice.
• Familiarize themselves with advanced organ preservation techniques, including perfusion and preservation methods, aimed at enhancing the viability of donated organs and expanding the transplantation window.
• Identify subject matter experts in the field of solid organ transplantation who can provide guidance and insights on the current and future prospects of genomics and diagnostics, enabling you to stay at the forefront of the field.